Migration notice:
On August 9th, 2025, Finsight.com market data will be renamed and migrated to CreditFlow, a more intuitive, comprehensive and accessible market data platform for all credit products.
Contact us
for more information.
Market Data
Pricing
Solutions
Log In
Market Overview
Parent Companies
Amneal Pharmaceuticals LLC
Amneal Pharmaceuticals LLC
Amneal Pharmaceuticals LLC
ABS
HYC
IGC
APAC
EMEA
LATM
USOA
Deals
Pulled
In Market
Priced
C/P
Sector
Status
Deal Name
Parent
Leads
Region
Date
HYC
HLTH
PRCD
AMRX 2025-1 (USD 2,100m)
Amneal Pharmaceuticals LLC
JPM
USOA
Jul 24, 2025
CCY
SIZE (M)
TNR
MTY
RNK
MO
SP
FI
TYPE
BNCH
IPT
GDNC
SPRD
CPN
NIC
PRICE
YFH
8,625.000
9
-
1md Nslh
S1
N+
-
Crudkszb
TMGA
-
EDAF+350
-
MNXT+35
-
27.25000
Tranche Comments
7 al: Comments: GUT2.1pw (ztnnjnp upzn GUT1.8pw) 7qp ctw UTDV+350 pf 99.75. Dtzzpv 0.50%. Sptt Tpzv 101 6n nzuf cptt;
Deal Comments
Qvfik Wvef Xefc Wsbf Bsfk
Use of Proceeds
Hxkia Jxad
Refinancing
Yes
HYC
HLTH
PRCD
AMRX cfr (USD 600m)
Amneal Pharmaceuticals LLC
USOA
Jul 23, 2025
Commentary
Upgrade Plan
Deal Flow
Upgrade Plan
B&I
BWICS & Inventory
This module is available on the Professional plan.
Learn more
Upgrade Plan
TRACE
This module is available on the Professional plan.
Learn more
Upgrade Plan
Research
Log In
Missing something? Tell us.